home / stock / dva / dva news


DVA News and Press, DaVita Inc. From 10/28/22

Stock Information

Company Name: DaVita Inc.
Stock Symbol: DVA
Market: NYSE
Website: davita.com

Menu

DVA DVA Quote DVA Short DVA News DVA Articles DVA Message Board
Get DVA Alerts

News, Short Squeeze, Breakout and More Instantly...

DVA - DaVita HealthCare Partners Non-GAAP EPS of $1.45 misses by $0.32, revenue of $2.95B misses by $30M

DaVita HealthCare Partners press release ( NYSE: DVA ): Q3 Non-GAAP EPS of $1.45 misses by $0.32 . Revenue of $2.95B (+0.3% Y/Y) misses by $30M . For FY2022, Adjusted diluted EPS to be in the range of $6.20 to $6.70 vs. prior view of $7.50 to $8.50 and consensu...

DVA - DaVita Inc. 3rd Quarter 2022 Results

DaVita Inc. 3rd Quarter 2022 Results PR Newswire DENVER , Oct. 28, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2022. "The third quarter was a challenging quarter for u...

DVA - DaVita Q3 2022 Earnings Preview

DaVita ( NYSE: DVA ) is scheduled to announce Q3 earnings results on Friday, October 28th, before market open. The consensus EPS Estimate is $1.77 (-25.0% Y/Y) and the consensus Revenue Estimate is $2.98B (+1.4% Y/Y). Over the last 2 years, DVA has beaten EPS estimat...

DVA - Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)

Summary Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. The stock has seemingly bottomed and began to retrace on massive buy-side volume while breaking out of one of its most important short-term resistance. In this tec...

DVA - GNOM: ETF Review And Healthcare Dashboard For October

Summary Pharmaceuticals and biotechnology have the best value and quality scores. Healthcare providers look undervalued relative to 11-year averages. Other healthcare industries don’t look attractive. Focus on a biotech ETF: GNOM (and why I don’t like it). ...

DVA - DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call

DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call PR Newswire DENVER , Oct. 14, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, Octob...

DVA - The DaVita Giving Foundation Provides $1.4 Million Grant Toward Addressing Food Insecurity

The DaVita Giving Foundation Provides $1.4 Million Grant Toward Addressing Food Insecurity PR Newswire Grant to enable nonprofit organizations in the Food Is Medicine Coalition to expand services for medically-tailored meals for individuals with chronic medical conditi...

DVA - DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling

Summary The Health Care sector has been a source of relative safety during this tumultuous September. While some large-caps in the space are catching bids, one smaller health care services and facilities company is sharply lower in 2022. Earnings are expected to improve, but t...

DVA - The 7 Most Undervalued Mid-Cap Stocks to Buy Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s up for debate whether the stock market downturn has reached or is close to reaching the “bottoming out” stage, but there are many opportunities out there. While most of the best opportunities are a...

DVA - IYH: Healthcare Dashboard For September

Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...

Previous 10 Next 10